Relative dominance of HLA-B*07 restricted CD8+ T-lymphocyte immune responses to human cytomegalovirus pp65 in persons sharing HLA-A*02 and HLA-B*07 alleles.
about
Ex vivo SIV-specific CD8 T cell responses in heterozygous animals are primarily directed against peptides presented by a single MHC haplotypeImmune Reconstitution after Allogeneic Hematopoietic Stem Cell TransplantationComprehensive Analysis of the Naturally Processed Peptide Repertoire: Differences between HLA-A and B in the ImmunopeptidomeDevelopment of a humanized HLA-A2.1/DP4 transgenic mouse model and the use of this model to map HLA-DP4-restricted epitopes of HBV envelope proteinImmunogenicity of virosomal adjuvanted trivalent influenza vaccination in allogeneic stem cell transplant recipients.HLA Alleles Associated with Delayed Progression to AIDS Contribute Strongly to the Initial CD8(+) T Cell Response against HIV-1.Sequential anti-cytomegalovirus response monitoring may allow prediction of cytomegalovirus reactivation after allogeneic stem cell transplantation.Presentation of an immunodominant immediate-early CD8+ T cell epitope resists human cytomegalovirus immunoevasion.A panel of artificial APCs expressing prevalent HLA alleles permits generation of cytotoxic T cells specific for both dominant and subdominant viral epitopes for adoptive therapy.High-functional-avidity cytotoxic T lymphocyte responses to HLA-B-restricted Gag-derived epitopes associated with relative HIV controlInsights into HLA-restricted T cell responses in a novel mouse model of dengue virus infection point toward new implications for vaccine design.Vaccine properties of a novel marker gene-free recombinant modified vaccinia Ankara expressing immunodominant CMV antigens pp65 and IE1.CMV reactivation drives posttransplant T-cell reconstitution and results in defects in the underlying TCRβ repertoireClinical evaluation of safety and immunogenicity of PADRE-cytomegalovirus (CMV) and tetanus-CMV fusion peptide vaccines with or without PF03512676 adjuvant.Immunotherapy with Donor T Cells Sensitized with Overlapping Pentadecapeptides for Treatment of Persistent Cytomegalovirus Infection or Viremia.Measles Virus Epitope Presentation by HLA: Novel Insights into Epitope Selection, Dominance, and Microvariation.A novel approach to evaluate the immunogenicity of viral antigens of clinical importance in HLA transgenic murine models.Age-associated increase of low-avidity cytomegalovirus-specific CD8+ T cells that re-express CD45RANovel strategies for adoptive therapy following HLA disparate transplantsT-cell depleted allogeneic hematopoietic cell transplants as a platform for adoptive therapy with leukemia selective or virus-specific T-cells.Virus-specific T-cell banks for 'off the shelf' adoptive therapy of refractory infections.Sequence-based human leukocyte antigen-B typing of patients infected with Ebola virus in Uganda in 2000: identification of alleles associated with fatal and nonfatal disease outcomes.Preconditioning therapy with lentiviral vector-programmed dendritic cells accelerates the homeostatic expansion of antigen-reactive human T cells in NOD.Rag1-/-.IL-2rγc-/- mice.Heat shock protein 70/peptide complexes: potent mediators for the generation of antiviral T cells particularly with regard to low precursor frequenciesAltered decamer and nonamer from an HLA-A0201-restricted epitope of Survivin differentially stimulate T-cell responses in different individualsCross-presentation of HCMV chimeric protein enables generation and measurement of polyclonal T cells.Ex vivo induction of viral antigen-specific CD8 T cell responses using mRNA-electroporated CD40-activated B cells.Identification of a naturally processed cytotoxic CD8 T-cell epitope of coxsackievirus B4, presented by HLA-A2.1 and located in the PEVKEK region of the P2C nonstructural protein.Adoptive transfer and selective reconstitution of streptamer-selected cytomegalovirus-specific CD8+ T cells leads to virus clearance in patients after allogeneic peripheral blood stem cell transplantation.Analysis of the human cytomegalovirus pp65-directed T-cell response in healthy HLA-A2-positive individuals.Comprehensive Analysis of Cytomegalovirus pp65 Antigen-Specific CD8+ T Cell Responses According to Human Leukocyte Antigen Class I Allotypes and Intraindividual Dominance.Evaluation of cytomegalovirus-specific cytotoxic T-lymphocytes in patients with the HLA-A*02 or HLA-A*24 phenotype undergoing hematopoietic stem cell transplantation.Extensive major histocompatibility complex class I binding promiscuity for Mycobacterium tuberculosis TB10.4 peptides and immune dominance of human leucocyte antigen (HLA)-B*0702 and HLA-B*0801 alleles in TB10.4 CD8 T-cell responses
P2860
Q27322650-F04D534B-374C-4A47-B37E-BC951941AD33Q28072627-568D6BE0-8489-4949-8B2A-11EBEC409C6FQ28548093-084D4705-BC09-41CD-BEFD-C9403C479D09Q28731516-5BA1E17F-C7CF-4728-885B-9DD2DB92A3EBQ30373149-3F0C2AE6-8495-46E8-83AD-93D9F72C6CA8Q33262230-A32DD4D6-A190-4AB3-9ADC-077CDE044E2FQ34524941-44D84CD8-2BFF-476F-9DB7-6C2B767F9AE9Q34743762-90806F3D-D6CD-48CE-A898-0D2E670D3E48Q34815702-6714919B-0370-477E-9DC0-EC254B641A3CQ35192655-0E87EE74-A862-487C-BF12-FD01EA59ADC4Q35268996-349C2F6B-46F0-4254-A9F9-A2386A861744Q35751946-60C448C4-FEF2-4149-867B-FD9AFF553963Q35757381-02B7BDD3-9530-4922-8CEF-BD7804B297B9Q35842287-87A6AF96-1535-498B-925D-BA3C5803C2BCQ35958223-1DBDAEFF-4809-4F93-A149-EA2835E0E6F0Q36238731-151CCAD4-1105-4B21-9472-CF9616D9FB99Q36960608-02D07FAB-679F-4528-8AD5-A8B3C7A89E25Q37077310-24482F05-3E3D-4E7A-9B07-FB6FD0014B57Q37504394-51BECBED-5374-4D2D-8F6D-81D88EDAD31CQ38514497-177610FE-1325-4CF2-BA92-D6179F0D1A01Q38797555-D303B859-45FF-4737-9A0B-1EF0ABE4B6FAQ38877091-F2940527-E519-405C-865A-DCFA6D20F583Q38899411-879B217E-5B9C-4EFB-8764-41A87F951890Q39156328-8CB1229C-450D-4D0E-AC7F-8BAF3438E655Q39592383-84149A6F-AF67-43BC-B8F5-11AB4F9F285AQ39895985-8C1C0FB8-89FA-422A-AE1C-91C17E48ED73Q40454655-E3A3EDE1-EC73-4FD6-8D2C-8F4D93AF3B48Q40585877-B496E7EA-152C-4FEB-949B-ABAB574C268CQ45370775-D510DFCB-3A2F-42CE-AD07-9E4EBB37D36AQ46678222-65177ED6-324D-4A86-9577-CDD7930D8585Q47111092-6523E7E2-A399-4056-9BD6-B3109485B77BQ53660426-0FFBB9A2-79EB-4FE7-A14F-3E23FA543856Q57209233-42D34C9D-6193-4FDF-91B4-A5BE435DAFAE
P2860
Relative dominance of HLA-B*07 restricted CD8+ T-lymphocyte immune responses to human cytomegalovirus pp65 in persons sharing HLA-A*02 and HLA-B*07 alleles.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Relative dominance of HLA-B*07 ...... HLA-A*02 and HLA-B*07 alleles.
@en
Relative dominance of HLA-B*07 ...... HLA-A*02 and HLA-B*07 alleles.
@nl
type
label
Relative dominance of HLA-B*07 ...... HLA-A*02 and HLA-B*07 alleles.
@en
Relative dominance of HLA-B*07 ...... HLA-A*02 and HLA-B*07 alleles.
@nl
prefLabel
Relative dominance of HLA-B*07 ...... HLA-A*02 and HLA-B*07 alleles.
@en
Relative dominance of HLA-B*07 ...... HLA-A*02 and HLA-B*07 alleles.
@nl
P2093
P1433
P1476
Relative dominance of HLA-B*07 ...... HLA-A*02 and HLA-B*07 alleles.
@en
P2093
Corinna La Rosa
John A Zaia
John C Brewer
John M Leedom
Joybelle Martinez
Maria C Villacres
Rebecca Maas
Shahram Mekhoubad
Simon F Lacey
Stephen J Forman
P304
P356
10.1016/S0198-8859(03)00028-4
P577
2003-04-01T00:00:00Z